| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $47.5M | +123.7% |
| R&D Expense | $307K | +448.2% |
| SG&A Expense | $23.1M | +12.0% |
| Operating Income | $2.6M | +120.1% |
| Interest Expense | $4.1M | +19.9% |
| Pre-tax Income | -$71K | +99.6% |
| Income Tax | $365K | — |
| Net Income | -$436K | +97.3% |
| EPS (Basic) | -$0.02 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $26.6M | +100.7% |
| Accounts Receivable | $12.9M | +46.2% |
| Current Assets | $44.1M | +64.3% |
| Total Assets | $44.9M | +67.3% |
| Current Liabilities | $6.9M | -8.4% |
| Long-term Debt | $19.3M | -37.5% |
| Total Liabilities | $50.8M | +32.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $27.0M | +257.4% |
| Financing Cash Flow | -$13.6M | -305.1% |
| +96.7% |
| EPS (Diluted) | -$0.02 | +96.7% |
| Stockholders' Equity |
| -$5.9M |
| +49.5% |